Alberta putting $81.5M toward goal of making its own pharmaceuticals, therapeutics
In chasing its ambitions to make vaccines and other pharmaceuticals and therapeutic products within its boundaries, Alberta is committing more than $80 million to its life sciences industry.
The dollars were announced in the spring, when Jason Kenney's government began soliciting proposals related to vaccine development and manufacturing.
Revealing the successful applicants Wednesday -- researchers at the University Alberta, as well as three private companies -- Premier Jason Kenney said "vaccine nationalism" seen earlier in the COVID-19 pandemic exemplifies the significance of biosecurity.
"Those jurisdictions assured themselves first access to available vaccines early on, so we were not the first in the queue. And that, frankly, cost lives," he told reporters, speaking at the U of A's Li Ka Shing Centre of Health Research Innovation.
"Moreover, I think with the global constraints on supply chains right across the world and every sector of the economy, I think there's a renewed appreciation of the need for us to onshore production of essential products."
'CUTTING-EDGE TECHNOLOGY'
The U of A's Li Ka Shing Institute of Virology will receive the largest chunk of the provincial government cash: $55.1 million.
Dr. Matthias Götte, who helped write the grant application, said some of the money will be put toward upgrading the U of A's Biosafety Level 3 lab and the Alberta Cell Therapy Manufacturing facility.
Another portion will be dedicated to building a facility for cryogenic electron microscopy. Essentially a microscope, the technology allows researchers to "zoom into the virus" and look at its structures that could potentially be targeted by a vaccine or therapy, Götte explained.
"This is cutting-edge technology. It is vital. It is extremely important that we have this technology here in Alberta," he said. "The entire structural biology, worldwide, will move into this direction."
He said he expects his teams to deliver results very soon from work they started two years ago, and by leveraging that and the provincial investment, to be able to raise more funding from Ottawa or institutions like the National Institutes of Health Informatics.
Alberta's 2021 budget renewed $20 million over four years for the Li Ka Shing institute, whose director was awarded the Nobel Prize in 2020 for his part in the discovery of the hepatitis C virus in 1989, for which the researchers have since moved on to making a vaccine.
INVESTMENT IN PRIVATE INDUSTRY
The rest of the money represents 10 per cent of project funding for three other proposals, contingent on the applicants also securing money from the federal government.
A total of $15.5 million will be provided to Entos Pharmaceuticals to establish a commercial manufacturing facility in Edmonton. The company builds genetic medicines with its own drug delivery system, with which it developed a COVID-19 vaccine that is entering second-phase clinical trials.
"It's one thing to discover and develop an innovative therapy, but it's another thing entirely to manufacture it at scale necessary both for late-stage clinical trials and ultimately for treatments that you or I or anyone of our family can take," CEO and co-founder Dr. John Lewis told media.
"So that's why Entos is so grateful for this announcement… The committed funding when paired with federal and private support will enable us to create a world-class facility that can produce not only COVID vaccines, but also future genetic medicines."
The company also recently signed an agreement to create candidate products for BioMarin Pharmaceuticals.
Another $5.6 million will go to Edmonton-based Applied Pharmaceutical Innovation to build a research, commercialization and manufacturing cluster, supporting growth of the Canadian Critical Drug Initiative.
Calgary's Northern RNA will receive $5 million to expand its capacity. The company, less than a year old, specializes in the manufacturing of essential raw materials needed for manufacturing messenger RNA. Co-founder and president Brad Stevens said his company can address one supply bottleneck by manufacturing lipids.
FEDERAL GOVERNMENT 'RECEPTIVE'
Although the provincial funding to the private companies is dependent on federal financial support, both Kenney and the CEOs expressed confidence they'd see Ottawa come through.
Kenney called the money from the Alberta government a way to "prime the pump, hopefully to attract that federal funding and we will be calling on the federal government to do just that."
"They are receptive, but no final decisions have yet been made."
"This funding sends a very, very critical message to federal partners that Alberta really sees its role in the supply chain," Applied Pharmaceutical Innovation CEO Andrew MacIsaac added.
"A lot of the investments in vaccine production around the world have come from the federal level, working in conjunction with the regional areas. So I think that this is a great first step and….will lead to tremendous benefits to the province."
The federal government has committed $2.2 billion to supporting biomanufacturing.
CTVNews.ca Top Stories
Quebec nurse had to clean up after husband's death in Montreal hospital
On a night she should have been mourning, a nurse from Quebec's Laurentians region says she was forced to clean up her husband after he died at a hospital in Montreal.
Cuban government apologizes to Montreal-area family after delivering wrong body
Cuba's foreign affairs minister has apologized to a Montreal-area family after they were sent the wrong body following the death of a loved one.
What is changing about Canada's capital gains tax and how does it impact me?
The federal government's proposed change to capital gains taxation is expected to increase taxes on investments and mainly affect wealthy Canadians and businesses. Here's what you need to know about the move.
'Anything to win': Trudeau says as Poilievre defends meeting protesters
Prime Minister Justin Trudeau is accusing Conservative Leader Pierre Poilievre of welcoming 'the support of conspiracy theorists and extremists,' after the Conservative leader was photographed meeting with protesters, which his office has defended.
Northern Ont. lawyer who abandoned clients in child protection cases disbarred
A North Bay, Ont., lawyer who abandoned 15 clients – many of them child protection cases – has lost his licence to practise law.
Boeing's financial woes continue, while families of crash victims urge U.S. to prosecute the company
Boeing said Wednesday that it lost US$355 million on falling revenue in the first quarter, another sign of the crisis gripping the aircraft manufacturer as it faces increasing scrutiny over the safety of its planes and accusations of shoddy work from a growing number of whistleblowers.
Bank of Canada officials split on when to start cutting interest rates
Members of the Bank of Canada's governing council were split on how long the central bank should wait before it starts cutting interest rates when they met earlier this month.
Fair in Ontario, flurries in Labrador: Weather systems make for an erratic spring
"It's a bit of a complicated pattern; we've got a lot going on," said Jennifer Smith of the Meteorological Service of Canada in an interview with CTVNews.ca on Wednesday. "[As is] typical with weather, all of these things are related."
Police tangle with students in Texas and California as wave of campus protest against Gaza war grows
Police tangled with student demonstrators in Texas and California while new encampments sprouted Wednesday at Harvard and other colleges as school leaders sought ways to defuse a growing wave of pro-Palestinian protests.